CoChat

Nitrate–Nitrite–Nitric Oxide Pathway in Pulmonary Arterial Hypertension Therapeutics

Open access
Sparacino-Watkins, Courtney E., Lai, Yen-Chun, Gladwin, Mark T. · 2012 · Circulation
Cited by 49

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Pulmonary arterial hypertension (PAH) is a disorder characterized by elevated vascular resistance in pulmonary arterioles. Progressive increases in pulmonary vascular resistance and pulmonary artery pressures result in right heart failure and reduced cardiac output. Patients experience progressive exertional dyspnea, right heart failure, syncope, and ultimately death. The common pathophysiological features of PAH include pulmonary vasoconstriction, intimal and smooth muscle proliferation, in situ thrombosis, and pathological remodeling of pulmonary arterial circulation. Although the origin of PAH is multifactorial, impairments in vasodilator (nitric oxide [NO] and prostaglandin signaling) and vasoconstrictor (endothelin-1, reactive oxygen species, angiotensin II) pathways underlie the evolution of early disease.1 Based on this knowledge, drugs that enhance the NO signaling pathways (phosphodiesterase 5 inhibitors), the prostenoids, and endothelin receptor blockers, have been developed and approved for PAH-specific therapy. Article see p 2922 Inhaled NO gas can alleviate vasoconstriction and may modulate cellular proliferative responses, but NO therapy is limited by the need for continuous inhalation, NO reactions with oxygen to form nitrogen dioxide, and special delivery devices. It is now appreciated that inorganic nitrite and nitrate are bio-transformed to NO via the nitrate-to-nitrite-to-NO pathway,2 leading to studies with inhaled nitrite as an alternative to NO gas inhalation.3,4 In this issue of Circulation , Baliga and colleagues5 investigate the nitrate-to-nitrite-to-NO pathway by studying the effects of oral nitrite and nitrate on preclinical mouse and rat models of PAH, and then attempt to characterize the enzymes that regulate bioconversion of nitrite to NO. They find that both nitrate and nitrite delivered in drinking water can prevent and reverse experimental PAH in the hypoxic and bleomycin mouse models, which is consistent with published models for in vivo conversion of nitrite to NO.6–8 They also provide unexpected evidence that eNOS may have nitrite reductase …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.112.107821

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 49

Metadata

Authors
Sparacino-Watkins, C. E., Lai, Y.-C., & Gladwin, M. T.
Venue
Circulation
Published
2012-06-12
Volume
125
Issue
23
Pages
2824-2826
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2113170838
Cited by
49
References
27
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nitrate–Nitrite–Nitric Oxide Pathway in Pulmonary Arterial Hypertension Therapeutics. https://app.cochat.ai/papers/10.1161/circulationaha.112.107821
The paper
Sparacino-Watkins, C. E., Lai, Y.-C., & Gladwin, M. T. (2012). Nitrate–Nitrite–Nitric Oxide Pathway in Pulmonary Arterial Hypertension Therapeutics. Circulation. https://doi.org/10.1161/circulationaha.112.107821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.